Savara Inc
Advertisement
Savara Inc. is a clinical-stage biopharmaceutical company headquartered in Langhorne, PA. Specializing in rare respiratory diseases, the company is committed to advancing treatment options for individuals affected by these conditions.
Driven by a dedication to innovation, Savara's science is at the forefront of developing therapies for rare respiratory ailments. With a focus on autoimmune pulmonary alveolar proteinosis (aPAP), the company's lead product candidate, MOLBREEVI, is currently in Phase 3 development.
Savara's research and development efforts are supported by a team of experts and a commitment to providing valuable information to investors and the medical community. Through a patient-centric approach, Savara aims to breathe new life into the treatment of aPAP and improve the lives of those living with this rare respiratory disease.
Generated from the website content
Also at this address
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.
Advertisement
